Results 171 to 180 of about 56,849 (307)

V2CTx MXene as a Sacrificial Promoter for NiFe Catalyst for Anion Exchange Membrane Electrolyzers

Advanced Science, EarlyView.
These findings demonstrate that V2CTx functions beyond passive conductive support as an active electronic participant whose structural legacy sustains durable performance even after vanadium leaching in Anion Exchange Membrane (AEM) Electrolysers. ABSTRACT Nickel‐iron layered double hydroxides (NiFe‐LDH) show excellent activity, their poor conductivity
Bastian Schmiedecke, Can Kaplan, Karuppasamy Dharmaraj, Axel Zuber, Merve Buldu‐Aktürk, Ningjun Chen, Mailis Lounasvuori, Xuyun Guo, Valeria Nicolosi, Thorsten Schultz, Norbert Koch, Johanna Rosen, Michelle P. Browne   +12 more
wiley   +1 more source

Backbone‐Length‐Optimized Inhibitors Deliver Long‐Retention Selectivity in Area‐Selective ALD of VO2

Advanced Science, EarlyView.
Area‐selective VO2 ALD is found to depend critically on inhibitor backbone length, which governs physisorption, chemisorption stability, and packing efficiency in a coupled manner. An intermediate backbone‐length achieves the best long‐retention selectivity, establishing a chemically and geometrically grounded design principle for small‐molecule ...
Hae Lin Yang, Eun Chong Cho, Minchan Kim, Hye In Park, Ga‐young Lee, Seunghwan Lee, Beomseok Kim, Changhwa Jung, Youngkwon Kim, Jin‐Seong Park   +9 more
wiley   +1 more source

Nucleic Acid Therapeutics for “Undruggable” Cancer Targets: Mechanisms, Challenges, and Prospects

Advanced Science, EarlyView.
Nucleic acid therapeutics bypass the structural limitations of conventional drugs by targeting mRNA rather than proteins. This review examines how antisense oligonucleotides, siRNAs, miRNAs, aptamers, and mRNA vaccines intervene against historically undruggable oncoproteins including Ras, MYC, and p53, highlighting mechanistic advances, delivery ...
Feng Xu, Ke Wang, Kaizhong Lu, Tianlun Hou, Yuan Chen, Xian Wang, Hongchuan Jin   +6 more
wiley   +1 more source

Selective Oxidation of Glycolaldehyde to Glyoxal Using Ruthenium Complex Catalysts. [PDF]

Chempluschem
Sagawa T, Kondo A, Hashizume M.
europepmc   +1 more source

Lipid Status of A2780 Ovarian Cancer Cells after Treatment with Ruthenium Complex Modified with Carbon Dot Nanocarriers: A Multimodal SR-FTIR Spectroscopy and MALDI TOF Mass Spectrometry Study. [PDF]

Cancers (Basel), 2022
Nešić MD, Dučić T, Algarra M, Popović I, Stepić M, Gonçalves M, Petković M.   +6 more
europepmc   +1 more source

Strain‐Preserving Transfer of Freestanding Oxide Membranes for Tunable Magnetic Anisotropy

Advanced Science, EarlyView.
An epoxy‐assisted exfoliation and transfer strategy circumvents the trade‐off between structural flexibility and strain tunability in freestanding oxide membranes. Epitaxial strain is effectively preserved, enabling versatile and robust control of magnetic anisotropy without sacrificing flexibility.
Jinfeng Zhang, Yuyue Zhao, Shouzhe Dong, Jingdi Lu, Qing Wang, Fang Xu, Ao Wang, Kunjie Dai, Yueming Huang, Zhengguo Liang, Qiming Lv, Houbing Huang, Wenbin Wu, Lingfei Wang   +13 more
wiley   +1 more source

Yeast Phenomic Analysis Reveals DNA Repair, pH Homeostasis, and Ribosomal Biogenesis as Modulators of Anticancer Ruthenium Complex KP1019. [PDF]

Int J Mol Sci
Bible AF, Blackman JS, Rodgers JW, Gary SR, Rainey M, Miller ME, Stepanov A, Hartman JL, Stultz LK, Hanson PK.   +9 more
europepmc   +1 more source

Fabrication of graphene ruthenium-complex heterostructures

The aim of this study is to understand the photoresponse of a Ruthenium-complex/graphene heterostructure. Early work demonstrated that light detection by graphene field effect devices was enhanced by dropcasting Ruthenium Complex molecules.
Pernice, WHP, Hirtz, M, Ruben, M, Danneau, R, CINO, Alfonso Carmelo, STIVALA, Salvatore, BUSACCA, Alessandro, Bog, U, Walter, N, Winter, J, Schramm, F, Jang, H, Ahn, JH, Giambra, Marco Angelo, Du, R   +14 more
core  

Targeting KDM3B Elicits Anti‐tumor Immunity by Alleviating SHP1–mediated STING Suppression in Triple–Negative Breast Cancer

Advanced Science, EarlyView.
P3FI–90 treatment targets KDM3B, reshapes the epigenetic landscape, and suppresses SHP1 expression, thereby activating STING–TBK1–IRF3–type I IFN signaling pathway. Consequently, CD8+ T cells are recruited to the tumor site and activated to produce IFN–γ and GZMB, leading to the killing of TNBC cells.
Xiaolong Wang, Wenhao Li, Yifei Wang, Ning Zhang, Bing Chen, Wenjing Zhao, Lijuan Wang, Dan Luo, Qifeng Yang   +8 more
wiley   +1 more source

Seven-Coordinate Ruthenium Complex with an SiNN-Pincer Ligand as a Catalyst for Vinyl C─H Deuteration of Olefins. [PDF]

Chem Asian J
Komuro T, Mochizuki D, Ishiwata N, Tobita H, Hashimoto H.   +4 more
europepmc   +1 more source